Cargando…

AIM2 upregulation promotes metastatic progression and PD‐L1 expression in lung adenocarcinoma

Cancer metastasis leading to the dysfunction of invaded organs is the main cause of the reduced survival rates in lung cancer patients. However, the molecular mechanism for lung cancer metastasis remains unclear. Recently, the increased activity of inflammasome appeared to correlate with the metasta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Jing‐Quan, Lin, Che‐Hsuan, Lee, Hsun‐Hua, Chang, Wei‐Ming, Li, Li‐Jie, Su, Chia‐Yi, Lee, Kang‐Yun, Chiu, Hui‐Wen, Lin, Yuan‐Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807530/ https://www.ncbi.nlm.nih.gov/pubmed/36104978 http://dx.doi.org/10.1111/cas.15584

Ejemplares similares

Lactotransferrin Downregulation Serves as a Potential Predictor for the Therapeutic Effectiveness of mTOR Inhibitors in the Metastatic Clear Cell Renal Cell Carcinoma without PTEN Mutation
por: Zheng, Jing-Quan, et al.
Publicado: (2021)

FBXL7 Upregulation Predicts a Poor Prognosis and Associates with a Possible Mechanism for Paclitaxel Resistance in Ovarian Cancer
por: Chiu, Hui-Wen, et al.
Publicado: (2018)

The Gαh/phospholipase C-δ1 interaction promotes autophagosome degradation by activating the Akt/mTORC1 pathway in metastatic triple-negative breast cancer
por: Lin, Hui-Yu, et al.
Publicado: (2020)

IMPA2 Downregulation Enhances mTORC1 Activity and Restrains Autophagy Initiation in Metastatic Clear Cell Renal Cell Carcinoma
por: Kuei, Chia-Hao, et al.
Publicado: (2020)

Upregulation of HOXA11 during the progression of lung adenocarcinoma detected via multiple approaches
por: Yang, Xia, et al.
Publicado: (2018)

KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma
por: Chen, Nan, et al.
Publicado: (2017)

The Co-Expression of Programmed Death-Ligand 1 (PD-L1) in Untreated EGFR-Mutated Metastatic Lung Adenocarcinoma
por: Hsu, Ping-Chih, et al.
Publicado: (2020)

Upregulation of PD‐L1 by SARS‐CoV‐2 promotes immune evasion
por: Huang, Hsiang‐Chi, et al.
Publicado: (2023)

AIM2 fosters lung adenocarcinoma immune escape by modulating PD-L1 expression in tumor-associated macrophages via JAK/STAT3
por: Ye, Hua, et al.
Publicado: (2023)

GBP5 Repression Suppresses the Metastatic Potential and PD-L1 Expression in Triple-Negative Breast Cancer
por: Cheng, Shun-Wen, et al.
Publicado: (2021)

Astaxanthin Ameliorates Ischemic-Hypoxic-Induced Neurotrophin Receptor p75 Upregulation in the Endothelial Cells of Neonatal Mouse Brains
por: Kuo, Min-Hsun, et al.
Publicado: (2019)

MNX1 facilitates the malignant progress of lung adenocarcinoma through transcriptionally upregulating CCDC34
por: Wu, Junhua, et al.
Publicado: (2023)

The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs
por: Kim, Seung Tae, et al.
Publicado: (2016)

IFN-γ surmounts PD-L1/PD1 inhibition to CAR-T cell therapy by upregulating ICAM-1 on tumor cells
por: Dong, E, et al.
Publicado: (2021)

PD-L1 Upregulation by the mTOR Pathway in VEGFR-TKI–Resistant Metastatic Clear Cell Renal Cell Carcinoma
por: Jeong, Se Un, et al.
Publicado: (2023)

Rationale and Clinical Research Progress on PD-1/PD-L1-Based Immunotherapy for Metastatic Triple-Negative Breast Cancer
por: Ren, Yifan, et al.
Publicado: (2022)

Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages
por: Xu, Di, et al.
Publicado: (2023)

Upregulation of PD-L1 predicts poor prognosis and is associated with miR-191-5p dysregulation in colon adenocarcinoma
por: Chen, Xiao-Yu, et al.
Publicado: (2018)

NEDD8 promotes radioresistance via triggering autophagy formation and serves as a novel prognostic marker in oral squamous cell carcinoma
por: Yuan, Tsu-Zong, et al.
Publicado: (2023)

TIMELESS upregulates PD-L1 expression and exerts an immunosuppressive role in breast cancer
por: Dong, Xinrui, et al.
Publicado: (2023)

A Systematic Review and Meta-analysis of PD-1 and PD-L1 Inhibitors Monotherapy in Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
por: Voutsadakis, Ioannis A
Publicado: (2020)

Upregulation of Fibrinogen-Like 1 Expression Contributes to Reducing the Progression of Preeclampsia
por: Cheng, Tsung-Lin, et al.
Publicado: (2021)

Upregulation of PD-L1 expression promotes epithelial-to-mesenchymal transition in sorafenib-resistant hepatocellular carcinoma cells
por: Xu, Gui-Li, et al.
Publicado: (2020)

Stenotrophomonas maltophilia promotes lung adenocarcinoma progression by upregulating histone deacetylase 5
por: Shen, Jiyu, et al.
Publicado: (2023)

Upregulation of Circulating PD-L1/PD-1 Is Associated with Poor Post-Cryoablation Prognosis in Patients with HBV-Related Hepatocellular Carcinoma
por: Zeng, Zhen, et al.
Publicado: (2011)

Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort A
por: Catenacci, D.V.T., et al.
Publicado: (2022)

Upregulation of CENPM facilitates lung adenocarcinoma progression via PI3K/AKT/mTOR signaling pathway: CENPM promotes lung adenocarcinoma progression
por: Liu, Chao, et al.
Publicado: (2021)

Aims and Initial Progress of TPMON Task
por: Andersson, A, et al.
Publicado: (2006)

Currently Used Laboratory Methodologies for Assays Detecting PD-1, PD-L1, PD-L2 and Soluble PD-L1 in Patients with Metastatic Breast Cancer
por: Jeong, Seri, et al.
Publicado: (2021)

Nintedanib enhances the efficacy of PD-L1 blockade by upregulating MHC-I and PD-L1 expression in tumor cells
por: Tu, Jingyao, et al.
Publicado: (2022)

Cytoophidium assembly reflects upregulation of IMPDH activity
por: Chang, Chia-Chun, et al.
Publicado: (2015)

Association of anemia and iron parameters with mortality among prevalent peritoneal dialysis patients in Taiwan: the AIM-PD study
por: Kuo, Ko-Lin, et al.
Publicado: (2022)

IL-17A promotes tumorigenesis and upregulates PD-L1 expression in non-small cell lung cancer
por: Liao, Hua, et al.
Publicado: (2023)

Risk stratification for lung adenocarcinoma on EGFR and TP53 mutation status, chemotherapy, and PD‐L1 immunotherapy
por: Wu, Chih‐Hsun, et al.
Publicado: (2019)

Methionine consumption by cancer cells drives a progressive upregulation of PD-1 expression in CD4 T cells
por: Pandit, Mahesh, et al.
Publicado: (2023)

Progress of research on PD-1/PD-L1 in leukemia
por: Cao, Huizhen, et al.
Publicado: (2023)

Increased expression of TAZ and associated upregulation of PD-L1 in cervical cancer
por: Han, Yanyan, et al.
Publicado: (2021)

5-FU-Induced Upregulation of Exosomal PD-L1 Causes Immunosuppression in Advanced Gastric Cancer Patients
por: Zhang, Min, et al.
Publicado: (2020)

NDAT Targets PI3K-Mediated PD-L1 Upregulation to Reduce Proliferation in Gefitinib-Resistant Colorectal Cancer
por: Huang, Tung-Yung, et al.
Publicado: (2020)

Kruppel like factor 16 promotes lung adenocarcinoma progression by upregulating lamin B2
por: Jiao, Xiaodan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dnj6j2ev4ris3hrbjlc3tm43kb